Value
5.7/10data confidence 83%| Component | Sub-score |
|---|---|
| P/E | 7.9 |
| P/S | 6.4 |
| EV/EBITDA | 6.3 |
| Fwd P/E | 8.8 |
| PEG | 1.0 |
- ▸Forward P/E: 12.5x
- ▸PEG: 8.96
XZO · Why this verdict
Why Exzeo Group (XZO) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score6.0/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Exzeo Group is a high-quality diversified insurance company with exceptional ROE of 59%, operating margins of 38%, and a Piotroski F-Score of 8 out of 9, while analysts project 66% upside to a consensus target near $22—though light analyst coverage and weak growth temper the near-term confidence.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
With a consensus analyst price target near $22.10 against a current price of $13.29, the implied upside of 66.3% is one of the largest in the screened universe, supported by a forward P/E of 11.6x and peer-relative value and quality rankings that validate the undervaluation thesis. Sentiment breakdown | Price rises above $18, closing more than 35% of the gap toward the analyst target of $22.10 within 12 months. | →Stable |
| CounterOnly 2 analysts cover the stock, making the 66% upside target statistically fragile—a single analyst revision could dramatically shift the consensus and eliminate the apparent discount. | ||
A debt-to-equity ratio of 2.5 creates a leverage penalty in the quality assessment, which is notable for a smaller insurer with a $1.2 billion market cap where leverage amplifies the impact of underwriting losses if claims experience deteriorates. Bear case | Debt-to-equity falls below 2.0 within 12 months as strong cash generation is applied toward balance sheet reduction. | →Stable |
| CounterInsurance companies routinely carry leverage as part of the float-funded business model, and a 2.5x ratio may be appropriate for the specific lines of insurance Exzeo underwrites. | ||
An ROE of 59% and operating margins of 38% place Exzeo in the top tier of its insurance peer group, ranking best-in-class for both ROE and margins versus direct competitors, and confirming a high-quality business generating strong returns on equity deployed. Quality breakdown | ROE remains above 40% and operating margins stay above 30% over the next 12 months as the underwriting discipline that produced these results continues. | →Stable |
| CounterInsurance companies with extremely high ROE ratios can be exposed to catastrophic loss events that rapidly compress margins, and the diversified insurance label provides limited information about the specific lines of business and their tail-risk profiles. | ||
The available earnings data shows a 25% positive surprise in the most recent quarter and an inline result before that, suggesting management is executing ahead of modest consensus expectations, though only 2 quarters of history are available. Earnings | Earnings beats continue in at least 2 of the next 4 quarters with average positive surprise above 10%. | →Stable |
| CounterWith only 2 quarters of earnings history in the data, the beat pattern is statistically insufficient to establish a trend, and one miss could reset expectations sharply. | ||
With a consensus analyst price target near $22.10 against a current price of $13.29, the implied upside of 66.3% is one of the largest in the screened universe, supported by a forward P/E of 11.6x and peer-relative value and quality rankings that validate the undervaluation thesis.
→StableSentiment breakdown
- Expectation
- Price rises above $18, closing more than 35% of the gap toward the analyst target of $22.10 within 12 months.
CounterOnly 2 analysts cover the stock, making the 66% upside target statistically fragile—a single analyst revision could dramatically shift the consensus and eliminate the apparent discount.
A debt-to-equity ratio of 2.5 creates a leverage penalty in the quality assessment, which is notable for a smaller insurer with a $1.2 billion market cap where leverage amplifies the impact of underwriting losses if claims experience deteriorates.
→StableBear case
- Expectation
- Debt-to-equity falls below 2.0 within 12 months as strong cash generation is applied toward balance sheet reduction.
CounterInsurance companies routinely carry leverage as part of the float-funded business model, and a 2.5x ratio may be appropriate for the specific lines of insurance Exzeo underwrites.
An ROE of 59% and operating margins of 38% place Exzeo in the top tier of its insurance peer group, ranking best-in-class for both ROE and margins versus direct competitors, and confirming a high-quality business generating strong returns on equity deployed.
→StableQuality breakdown
- Expectation
- ROE remains above 40% and operating margins stay above 30% over the next 12 months as the underwriting discipline that produced these results continues.
CounterInsurance companies with extremely high ROE ratios can be exposed to catastrophic loss events that rapidly compress margins, and the diversified insurance label provides limited information about the specific lines of business and their tail-risk profiles.
The available earnings data shows a 25% positive surprise in the most recent quarter and an inline result before that, suggesting management is executing ahead of modest consensus expectations, though only 2 quarters of history are available.
→StableEarnings
- Expectation
- Earnings beats continue in at least 2 of the next 4 quarters with average positive surprise above 10%.
CounterWith only 2 quarters of earnings history in the data, the beat pattern is statistically insufficient to establish a trend, and one miss could reset expectations sharply.
Per-dimension breakdown
Quality
9.2/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 10.0 |
| Gross margin | 10.0 |
| Op margin | 10.0 |
| Net margin | 10.0 |
| Current ratio | 8.9 |
| Moat | 6.9 |
| Piotroski F | 8.9 |
- ▸Excellent ROE: 59%
- ▸Strong margins: 38%
- ▸Strong Piotroski F-Score: 8/9
- ▸High-quality business
Growth
3.6/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 5.0 |
| EPS growth | 2.3 |
Momentum
5.9/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 2.1 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 7.5 |
| Volume | 0.0 |
- ▸Overbought bear rally (RSI 84)
- ▸Volume accumulation (rising OBV)
Sentiment
6.6/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 9.9 |
| erm sentiment | 5.0 |
- ▸Analyst upside: 76%
Insider
6.5/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 6.5 |
| insider conviction | 8.0 |
| holder change | 5.1 |
- ▸Modest insider buying — $1,271,052 (0.097% of mkt cap)
Peer rank
6.0/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 0.8 |
| quality rank | 9.2 |
| growth rank | 9.2 |
- ▸Superior ROE vs peers
- ▸Best-in-class margins
Technical
2.0/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 0.0 |
| support resistance | 1.0 |
| 52w position | 2.0 |
| gap | 5.0 |
Risk (lower is worse)
5.2/10data confidence 80%| Component | Sub-score |
|---|---|
| short interest | 7.6 |
| days to cover | 8.5 |
| volatility | 2.4 |
| debt equity | 2.5 |
Catalyst
7.5/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
How the verdict was assembled
Engine trigger
Multiple concerning factors. Consider reducing position.
Engine technical detail
verdict_path:
L4:PATH_F_SELLPassed (8)
- MOMENTUM:5.9>=5.5
- ASYMMETRY:3.3>=1.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:41d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (0)
none
Warning (0)
none
Reward-to-Risk
3.30
Upside
+49.5%
Downside
15.0%
Sizing output
AVOID
SetupUNKNOWN — No clear chart pattern; technical signals are mixed
EdgeNO_EDGE — No clear edge identified
SuitabilityAGGRESSIVE — MCap $1.3B<$5B
Investment implication
The F-path SELL output reflects an overall score of 4.5 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Quality at 9.2) was not enough to lift the adjusted overall above the threshold. Current asymmetry R:R is 3.30 — supplementary context, not the trigger for this path.
The strongest dimensions are Quality at 9.2, Catalyst at 7.5, and Sentiment at 6.6; the weakest are Technical at 2.0, Growth at 3.6, and Risk (lower is worse) at 5.2. The V9 engine cleared all gates, producing an asymmetric reward-to-risk of 3.30 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1An ROE of 59% and operating margins of 38% place Exzeo in the top tier of its insurance peer group, ranking best-in-class for both ROE and margins versus direct competitors, and confirming a high-quality business generating strong returns on equity deployed.
Trip ifROE falls below 30%, declining more than 49 percentage points from the current 59% level.
- P2With a consensus analyst price target near $22.10 against a current price of $13.29, the implied upside of 66.3% is one of the largest in the screened universe, supported by a forward P/E of 11.6x and peer-relative value and quality rankings that validate the undervaluation thesis.
Trip ifAnalyst consensus price target falls below $16, declining more than 27% from the current approximately $22 target.
- P3The available earnings data shows a 25% positive surprise in the most recent quarter and an inline result before that, suggesting management is executing ahead of modest consensus expectations, though only 2 quarters of history are available.
Trip ifEPS surprise falls below negative 10% in at least 2 of the next 4 quarters.
- P4A debt-to-equity ratio of 2.5 creates a leverage penalty in the quality assessment, which is notable for a smaller insurer with a $1.2 billion market cap where leverage amplifies the impact of underwriting losses if claims experience deteriorates.
Trip ifDebt-to-equity ratio rises above 4.0, increasing more than 60% above the current 2.5x level.